Jefferies analyst Roger Song maintained a Buy rating on TG Therapeutics (TGTX – Research Report) on January 2 and set a price target of $46.00.
In a report released on January 3, Catherine O’Brien from Goldman Sachs reiterated a Buy rating on Delta Air Lines (DAL – Research Report), ...
Only through repeated matches can a player develop instinctive responses to these ever-changing scenarios. But even the most ...